Institutional investors acquired a large stake in Gossamer Bio, a company based in the United States.
1 report, 1 independent
Updated Aug 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Institutional investors acquired a large stake in Gossamer Bio, a company based in the United States.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Gossamer Bio (United States)
company in San Diego, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.Institutional investors in Gossamer Bio, Inc. (NASDAQ:GOSS) see US$54m decrease in market cap last week, although long-term gains have benefitted them. Explore Gossamer Bio's Fair Values from the Com